Veradigm (NASDAQ:MDRX) Stock Price Up 14.1% - Time to Buy?

Key Points

• Veradigm Inc. shares surged 14.1% to $5.25 during trading, although this volume was significantly lower than the average, at only 1,535 shares compared to approximately 250,930.
• Wall Street analysts, including Wall Street Zen, have initiated coverage with a "hold" rating and set a consensus price target of $13.00 for the stock.
• Veradigm is a healthcare technology company offering solutions such as electronic health records and analytics, primarily servicing healthcare organizations in the U.S. and internationally.

Veradigm Inc. (NASDAQ:MDRX - Get Free Report)'s stock price traded up 14.1% on Friday . The company traded as high as $5.25 and last traded at $5.25. 1,535 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 250,930 shares. The stock had previously closed at $4.60.

Analyst Ratings Changes

Separately, Wall Street Zen assumed coverage on shares of Veradigm in a research note on Tuesday, May 20th. They issued a "hold" rating on the stock. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $13.00.

Veradigm Stock Performance

The firm's 50-day moving average price is $4.77 and its 200 day moving average price is $4.56.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.